drugset
drugset / Trial / NCT01535820

The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

NCT01535820 ↗

Phase 1 Completed 54 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the bioequivalence of the contraceptive hormones of ORTHO EVRA when the patch is applied with and without an adhesive overlay.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ethinyl estradiol Small molecule 0.75 mg Other
Subject norelgestromin Unknown 6 mg Other

Indications

No indication recorded.